Altret Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 22-06-2024
- Paid Up Capital ₹ 6.18 M
as on 22-06-2024
- Company Age 32 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 9.80 M
as on 22-06-2024
- Revenue -34.67%
(FY 2021)
- Profit 83.79%
(FY 2021)
- Ebitda 60.42%
(FY 2021)
- Net Worth 1.70%
(FY 2021)
- Total Assets -0.71%
(FY 2021)
About Altret Chemicals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 6.18 M.
The company has closed loans amounting to ₹9.80 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Akbar Lokhandwala, Sheesh Lokhandwala, and Abbas Saherwala serve as directors at the Company.
- CIN/LLPIN
U45200GJ1992PTC017796
- Company No.
017796
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jun 1992
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Surat, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Altret Chemicals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Akbar Lokhandwala  | Managing Director | 10-Jun-1992 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sheesh Lokhandwala | Whole-Time Director | 07-Jul-1993 | Current |
| Abbas Saherwala | Whole-Time Director | 01-Apr-2002 | Current |
Financial Performance of Altret Chemicals.
Altret Chemicals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 34.67% decrease. The company also saw a substantial improvement in profitability, with a 83.79% increase in profit. The company's net worth moved up by a moderate rise of 1.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Altret Chemicals?
In 2020, Altret Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Surat Peoples Co-Operative Bank Limited Creation Date: 26 Mar 2009 | ₹4.00 M | Satisfied |
The Surat People's Co. Op. Bank Ltd. Creation Date: 31 Oct 2003 | ₹3.00 M | Satisfied |
Dena Bank Creation Date: 05 Apr 2003 | ₹2.80 M | Satisfied |
How Many Employees Work at Altret Chemicals?
Altret Chemicals has a workforce of 7 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Altret Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Altret Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
